Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

426
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

399
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

14.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects.

Clinical and experimental immunology·2018
Same author

Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.

Journal of thrombosis and haemostasis : JTH·2016
Same author

OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.

Thrombosis research·2016
Same author

Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside.

Auto- immunity highlights·2015
Same author

A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions.

Clinical and experimental rheumatology·2013
Same author

Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.

International journal of immunopathology and pharmacology·2013

Related Experiment Video

Updated: Mar 3, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.3K

Markers of increased thrombin generation.

D Prisco1

  • 1Clinica Medica I, Università degli Studi di Firenze.

La Ricerca in Clinica E in Laboratorio
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Directly measuring plasma thrombin is challenging. Current indirect markers for thrombin generation, like fibrinopeptide A, are considered the gold standard, but others require more validation or are not for routine use.

More Related Videos

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.5K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K

Related Experiment Videos

Last Updated: Mar 3, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.3K
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.5K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K

Area of Science:

  • Biochemistry
  • Hematology
  • Clinical Chemistry

Background:

  • Increased thrombin generation is a key indicator of blood clotting activation.
  • Direct measurement of plasma thrombin is currently not feasible due to a lack of reliable methods.
  • Indirect approaches are necessary to assess thrombin generation.

Discussion:

  • The fibrinopeptide A assay is considered the 'gold standard' for measuring thrombin generation.
  • Thrombin-antithrombin complexes assay requires further validation for reliable use.
  • More recent markers like F1+2 fragment and protein C activation peptide are not yet available for routine clinical application.

Key Insights:

  • Accurate assessment of thrombin generation remains a significant challenge in clinical diagnostics.
  • The fibrinopeptide A assay is the most established indirect method, despite limitations.
  • Ongoing research aims to develop and validate new, accessible markers for thrombin generation.

Outlook:

  • Further validation of existing markers is needed to improve diagnostic accuracy.
  • Development of novel, routine-use assays for thrombin generation is a critical area for future research.
  • Improved methods for assessing thrombin generation will enhance the management of thrombotic disorders.